MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from public
offerings
$12,663K
Proceeds from warrant
inducement financing
$4,136K
Proceeds from registered
direct offering
$3,503K
Proceeds from exercise of
pre-funded warrants
$5K
Net cash provided by
financing activities
$17,119K
Effect of exchange rate
changes on cash
$6K
Canceled cashflow
$3,188K
Net increase
(decrease) in cash and...
$785K
Canceled cashflow
$16,340K
Repayment of principal on
related party term notes...
$2,000K
Payment of financing
costs
$725K
Repayment of principal on
related party bridge...
$200K
Repayment of principal on
term notes payable
$200K
Repayment of financing
lease obligations
$63K
Stock-based compensation
$1,658K
Depreciation and
amortization expense
$1,228K
Change in fair value of
other liabilities and...
$84K
Net cash used in
operating activities
-$16,249K
Net cash used in
investing activities
-$91K
Canceled cashflow
$2,970K
Net loss
-$16,004K
Accrued expenses and
other current...
-$1,185K
Purchases of machinery and
equipment
$91K
Operating lease right of
use liability
-$1,068K
Accounts payable
-$924K
Prepaid expenses and
other current assets
$38K
Back
Back
Cash Flow
source: myfinsight.com
Calidi Biotherapeutics, Inc. (CLDI)
Calidi Biotherapeutics, Inc. (CLDI)